Palliative resection of the primary tumor in 442 metastasized neuroendocrine tumors of the pancreas: a population-based, propensity score-matched survival analysis

There is an ongoing debate on whether palliative removal of the primary tumor may result in a survival benefit for patients with incurable stage IV pancreatic neuroendocrine tumors (P-NET). The objective of this study was to assess whether palliative resection of the primary tumor in patients with i...

Full description

Saved in:
Bibliographic Details
Main Authors: Hüttner, Felix (Author) , Schneider, Lutz (Author) , Tarantino, Ignazio (Author) , Warschkow, René (Author) , Schmied, Bruno (Author) , Hackert, Thilo (Author) , Diener, Markus K. (Author) , Büchler, Markus W. (Author) , Ulrich, Alexis (Author)
Format: Article (Journal)
Language:English
Published: 22 July 2015
In: Langenbeck's archives of surgery
Year: 2015, Volume: 400, Issue: 6, Pages: 715-723
ISSN:1435-2451
DOI:10.1007/s00423-015-1323-x
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1007/s00423-015-1323-x
Get full text
Author Notes:Felix J. Hüttner, Lutz Schneider, Ignazio Tarantino, Rene Warschkow, Bruno M. Schmied, Thilo Hackert, Markus K. Diener, Markus W. Büchler, Alexis Ulrich
Description
Summary:There is an ongoing debate on whether palliative removal of the primary tumor may result in a survival benefit for patients with incurable stage IV pancreatic neuroendocrine tumors (P-NET). The objective of this study was to assess whether palliative resection of the primary tumor in patients with incurable stage IV P-NET has an impact on survival.
Item Description:Gesehen am 03.06.2020
Physical Description:Online Resource
ISSN:1435-2451
DOI:10.1007/s00423-015-1323-x